Provider

Ambient Clinical Analytics, a remote patient monitoring company that spun off from Mayo Clinic in 2013, has raised $1.

Last week the American Medical Association outlined a new set of recommendations on augmented intelligence, a type of technology that aims to extend, but not replace, a human medical expert’s insight and decision-making capabilities.

The new Rosalind Franklin Institute is investing £6m in ground-breaking initiatives that will disrupt the drug development process.

Findings from the final report of the Lord Darzi Review of Health and Care indicate advanced technologies offer an opportunity to shift the model of care from 'diagnose and treat' to 'predict and prevent', outlining a series of recommendations to accelerate access to innovation.

Medical tech company Medtronic is teaming up with Nutrino, an AI powered personalized nutrition platform.

To all of the people who work with machine learning and neural networks healthcare technologies, but can’t describe exactly how the gears are turning — don’t worry, you’re not alone.

Medical tech company Medtronic has just landed FDA clearance on its Deep Brain Stimulation (DBS) Clinical Programmer and ActivaProgramming application.

The FDA has granted Isreal-based DreaMed Diabetes a de novo request for its artificial intelligence-powered software for providers managing patients with Type 1 diabetes.

In the last few years consumer genomics has grown in both its offerings and legitimacy.

DyAnsys, a medical device company specializing in the autonomic nervous system, announced this week that it has received FDA approval for a wearable auricular neurostimulation device designed to treat symptoms of opioid withdrawal.